Literature DB >> 7889393

The treatment of epithelial ovarian cancer.

F Qazi1, W P McGuire.   

Abstract

The treatment and long-term survival of patients with ovarian cancer varies by stage. At present, five-year survival for patients with early-stage disease ranges from 50 to 95 percent, while five-year survival for patients with advanced-stage disease is less than 25 percent. Several new drugs with significant activity in advanced-stage ovarian cancer offer hope for increased long-term survival in the future. This article reviews the current and experimental approaches to the treatment of all stages of ovarian cancer.

Entities:  

Mesh：

Year:  1995        PMID： 7889393     DOI： 10.3322/canjclin.45.2.88

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  6 in total

1.  Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.

Authors:  Liang-Cheng Li; Shankar Jayaram; Lakshmy Ganesh; Lixia Qian; Jacob Rotmensch; Ajay V Maker; Bellur S Prabhakar
Journal:  Am J Obstet Gynecol       Date:  2011-05-27       Impact factor: 8.661

2.  Family history in ovarian cancer referral population.

Authors:  L A Berg; S Robert Young; K A Brooks; A M Davis; S Terry Smith
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

3.  Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary.

Authors:  Terence C Chua; Narayan Gopalakrishna Iyer; Khee Chee Soo
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

4.  Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer.

Authors:  M C McFadyen; M E Cruickshank; I D Miller; H L McLeod; W T Melvin; N E Haites; D Parkin; G I Murray
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

Review 5.  Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment.

Authors:  Tianyi Liu; Min Hou; Manyu Li; Cheng Qiu; Lin Cheng; Tianyu Zhu; Jinfeng Qu; Lanyu Li
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

6.  Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma.

Authors:  Marta Mendiola; Jorge Barriuso; Andrés Redondo; Adrián Mariño-Enríquez; Rosario Madero; Enrique Espinosa; Juan Angel Fresno Vara; Iker Sánchez-Navarro; Ginés Hernández-Cortes; Pilar Zamora; Elia Pérez-Fernández; María Miguel-Martín; Asunción Suárez; José Palacios; Manuel González-Barón; David Hardisson
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.